home / stock / immp / immp quote
Last: | $1.922 |
---|---|
Change Percent: | -0.93% |
Open: | $1.91 |
Close: | $1.94 |
High: | $1.99 |
Low: | $1.91 |
Volume: | 67,245 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.922 | $1.91 | $1.94 | $1.99 | $1.91 | 67,245 | 07-19-2024 |
$1.94 | $2 | $1.94 | $2.015 | $1.88 | 251,143 | 07-18-2024 |
$2 | $2.07 | $2 | $2.13 | $1.98 | 482,478 | 07-17-2024 |
$2.03 | $2.05 | $2.03 | $2.11 | $1.9505 | 384,682 | 07-16-2024 |
$2.04 | $2.21 | $2.04 | $2.2209 | $1.96 | 975,118 | 07-15-2024 |
$2.31 | $2.36 | $2.31 | $2.6 | $2.13 | 6,009,681 | 07-12-2024 |
$2.01 | $2 | $2.01 | $2.055 | $1.96 | 1,004,229 | 07-11-2024 |
$2 | $1.97 | $2 | $2 | $1.91 | 133,731 | 07-10-2024 |
$1.98 | $1.98 | $1.98 | $2 | $1.92 | 82,119 | 07-09-2024 |
$1.96 | $2 | $1.96 | $2.02 | $1.94 | 132,481 | 07-08-2024 |
$1.94 | $1.94 | $1.94 | $2 | $1.9 | 157,327 | 07-05-2024 |
$1.98 | $1.95 | $1.98 | $2.04 | $1.91 | 93,553 | 07-04-2024 |
$1.98 | $1.95 | $1.98 | $2.04 | $1.91 | 93,553 | 07-03-2024 |
$1.88 | $1.97 | $1.88 | $1.97 | $1.83 | 302,973 | 07-02-2024 |
$2.01 | $2.01 | $2.01 | $2.1 | $1.97 | 240,624 | 07-01-2024 |
$2.01 | $1.86 | $2.01 | $2.04 | $1.85 | 764,154 | 06-28-2024 |
$1.87 | $1.88 | $1.87 | $2.03 | $1.66 | 2,530,735 | 06-27-2024 |
$2.77 | $2.78 | $2.77 | $2.8 | $2.71 | 258,695 | 06-26-2024 |
$2.63 | $2.7 | $2.63 | $2.72 | $2.6 | 155,190 | 06-25-2024 |
$2.66 | $2.71 | $2.66 | $2.77 | $2.65 | 153,520 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a treatment approach not containing chemotherapy in patients with CPS <1 High complete response...